Share priceWell, in wilst of others who were not so kind to me i sold most of my shares, i guess i was lucky. A few weeks ago, it was obvious that sales were not that great!
And now a terrible downgrade while many small cap biotechs are surging
A question for mr. SPCEO ; even in your worst case sales scenario, we would be happy, but now your focus is on the very earle Nash.........You are not much expecting from Trogarzo anymore? And if that early Nash molecule is not that great, what to expect then for the near future ?
Let it be clear, i hope for the best for the company and thus for patients and so next also for sareholders!
Good luck all